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Abstract
© 2017  Izmailov,  Povysheva,  Bashirov,  Sokolov,  Fadeev,  Garifulin,  Naroditsky,  Logunov,
Salafutdinov,  Chelyshev,  Islamov  and  Lavrov.  The  gene  therapy  has  been  successful  in
treatment  of  spinal  cord  injury  (SCI)  in  several  animal  models,  although  it  still  remains
unavailable for clinical practice. Surprisingly, regardless the fact that multiple reports showed
motor recovery with gene therapy, little is known about molecular and cellular changes in the
post-traumatic spinal cord following viral vector- or cell-mediated gene therapy. In this study we
evaluated the therapeutic efficacy and changes in spinal cord after treatment with the genes
encoding  vascular  endothelial  growth  factor  (VEGF),  glial  cell-derived  neurotrophic  factor
(GDNF), angiogenin (ANG), and neuronal cell  adhesion molecule (NCAM) applied using both
approaches. Therapeutic genes were used for viral vector- and cell-mediated gene therapy in
two combinations: (1) VEGF+GDNF+NCAM and (2) VEGF+ANG+NCAM. For direct gene therapy
adenoviral vectors based on serotype 5 (Ad5) were injected intrathecally and for cell-mediated
gene delivery human umbilical cord blood mononuclear cells (UCB-MC) were simultaneously
transduced with three Ad5 vectors and injected intrathecally 4 h after the SCI. The efficacy of
both treatments was confirmed by improvement in behavioral (BBB) test. Molecular and cellular
changes following post-traumatic recovery were evaluated with immunofluorescent staining
using  antibodies  against  the  functional  markers  of  motorneurons  (Hsp27,  synaptophysin,
PSD95), astrocytes (GFAP, vimentin), oligodendrocytes (Olig2, NG2, Cx47) and microglial cells
(Iba1). Our results suggest that both approaches with intrathecal delivery of therapeutic genes
may support functional recovery of post-traumatic spinal cord via lowering the stress (down
regulation  of  Hsp25)  and  enhancing  the  synaptic  plasticity  (up  regulation  of  PSD95  and
synaptophysin), supporting oligodendrocyte proliferation (up regulation of NG2) and myelination
(up regulation of Olig2 and Cx47), modulating astrogliosis by reducing number of astrocytes
(down regulation of GFAP and vimetin) and microglial cells (down regulation of Iba1).
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